Pancreatic Cancer Trial, Recruiting NCT02361320 Sponsor: M.D. Anderson Cancer Center Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT02361320
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For pancreatic cancer patients:

  • You have been diagnosed with pancreatic cancer that has been confirmed by a tissue sample (biopsy)
  • Your cancer has not spread to distant parts of the body, but is either too complex to remove with surgery right away ("locally advanced") or is in a position that makes surgery difficult but possibly doable ("borderline resectable") — based on scans showing how the tumor relates to nearby blood vessels
  • You are generally able to carry out daily activities with little or no limitation (confirm with trial site what this means for you)
  • If you are a woman who could become pregnant, you must agree to use effective birth control and not breastfeed during the trial
  • Your doctor has recommended chemotherapy as part of your treatment for pancreatic cancer
  • You are willing to sign the trial consent form

For liver or bile duct cancer patients:

  • You have been diagnosed with either liver cancer (hepatocellular carcinoma) or bile duct cancer within the liver (intrahepatic cholangiocarcinoma), confirmed by a tissue sample or, in some cases, by specific scan findings
  • You may have one tumor or several tumors in the liver
  • You are generally able to carry out daily activities with little or no limitation (confirm with trial site what this means for you)
  • If you are a woman who could become pregnant, you must agree to use effective birth control during the trial
  • You may have previously had surgery, chemotherapy, certain targeted treatments to the liver, or tumour burning (ablation) procedures
  • You are either about to receive radiation therapy as your main treatment, or you have already received it within the last two years and have the relevant scans from before and after that treatment
  • You are willing to sign the trial consent form

Who may not be able to join:

  • Your cancer has spread to distant parts of the body (metastasis)
  • Your tumor is considered fully removable by surgery without any complications
  • You have unstable chest pain (angina) or moderate-to-severe heart failure
  • You currently have a fever or an active infection (note: long-term infections like hepatitis are generally still acceptable)
  • You have another health condition that would prevent you from safely receiving chemotherapy, radiation therapy, or a CT scan using contrast dye
  • You are pregnant (confirmed by a positive pregnancy test)
  • You are unable or unwilling to follow the study procedures and required follow-up visits
  • You currently have another active cancer, unless it is a common type of non-serious skin cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eugene Koay, M.D. Anderson Cancer Center

Phone: 713-563-2300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 March 2015
Est. completion
27 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Correlation Between Local Control and Changes in Mass Transport by Computed Tomography (CT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov